1. Home
  2. WHG vs ACHV Comparison

WHG vs ACHV Comparison

Compare WHG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$16.84

Market Cap

173.6M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.29

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
ACHV
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.6M
172.0M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
WHG
ACHV
Price
$16.84
$4.29
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.67
AVG Volume (30 Days)
6.4K
1.6M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
3.61%
N/A
EPS Growth
203.85
N/A
EPS
0.79
N/A
Revenue
$97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.47
N/A
Revenue Growth
3.21
N/A
52 Week Low
$14.51
$2.00
52 Week High
$18.99
$6.03

Technical Indicators

Market Signals
Indicator
WHG
ACHV
Relative Strength Index (RSI) 60.37 56.27
Support Level $17.28 $4.06
Resistance Level $18.68 $5.13
Average True Range (ATR) 0.66 0.42
MACD 0.07 0.05
Stochastic Oscillator 100.00 52.89

Price Performance

Historical Comparison
WHG
ACHV

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: